Induction of apoptosis in rat cardiocytes by A3 adenosine receptor activation and its suppression by isoproterenol.

Exp Cell Res

Gonda (Goldschmied) Medical Diagnostic Research Center, Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel.

Published: May 2000

The purpose of the present study was to investigate the mechanisms involved in the induction of apoptosis in newborn cultured cardiomyocytes by activation of adenosine (ADO) A3 receptors and to examine the protective effects of beta-adrenoceptors. The selective agonist for A3 ADO receptors Cl-IB-MECA (2-chloro-N6-iodobenzyl-5-N-methylcarboxamidoadenosine) and the antagonist MRS1523 (5-propyl-2-ethyl-4-propyl-3-(ethylsulfanylcarbonyl)-6-phenylpy rid ine-5-carboxylate) were used. High concentrations of the Cl-IB-MECA (> or = 10 microM) agonist induced morphological modifications of myogenic cells, such as rounding and retraction of cell body and dissolution of contractile filaments, followed by apoptotic death. In addition, Cl-IB-MECA caused a sustained and reversible increase in [Ca2+]i, which was prevented by the selective antagonist MRS1523. Furthermore, MRS1523 protected the cardiocytes if briefly exposed to Cl-IB-MECA and partially protected from prolonged (48 h) agonist exposure. Apoptosis induced by Cl-IB-MECA was not redox-dependent, since the mitochondrial membrane potential remained constant until the terminal stage of cell death. Cl-IB-MECA activated caspase-3 protease in a concentration-dependent manner after 7 h of treatment and more effectively after 18 h of exposure. Bcl-2 protein was readily detected in control cells, and its expression was significantly decreased after 24 and 48 h of treatment with Cl-IB-MECA. Beta-adrenergic stimulation antagonized the pro-apoptotic effects of Cl-IB-MECA, probably through a cAMP/protein kinase A-independent mechanism, since addition of dibutyryl-cAMP did not abolish the apoptosis induced by Cl-IB-MECA. Incubation of cultured myocytes with isoproterenol (5 microM) for 3 or 24 h almost completely abolished the increase in [Ca2+]i. Prolonged incubation of cardiomyocytes with isoproterenol and Cl-IB-MECA did not induce apoptosis. Our data suggest that the apoptosis-inducing signal from activation of adenosine A3 receptors (or counteracting beta-adrenergic signal) leads to the activation of the G-protein-coupled enzymes and downstream pathways to a self-amplifying cascade. Expression of different genes within this cascade is responsible for orchestrating either cardiomyocyte apoptosis or its protection.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10792615PMC
http://dx.doi.org/10.1006/excr.2000.4882DOI Listing

Publication Analysis

Top Keywords

cl-ib-meca
10
induction apoptosis
8
activation adenosine
8
ado receptors
8
antagonist mrs1523
8
increase [ca2+]i
8
apoptosis induced
8
induced cl-ib-meca
8
apoptosis
5
apoptosis rat
4

Similar Publications

Article Synopsis
  • Neuroinflammatory disorders are linked to mitochondrial dysfunction and transcriptional changes, particularly in activated microglia, which shows altered biogenesis and redox status.
  • This study utilized RNA sequencing to examine gene expression in microglia treated with adenosine A receptor modulators, revealing significant upregulation (over 40% of mitochondrial genes expressed differently) in response to treatment, highlighting their role in inflammation and oxidative stress.
  • The research also indicated improved mitochondrial function when using the adenosine A receptor antagonist in pro-inflammatory conditions, supporting the potential of targeting the adenosinergic system for therapeutic interventions in neuroinflammation.
View Article and Find Full Text PDF

Lipid Trolling to Optimize A Adenosine Receptor-Positive Allosteric Modulators (PAMs).

J Med Chem

July 2024

Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892, United States.

Article Synopsis
  • AAR positive allosteric modulators (PAMs) enhance the effects of AAR agonists by binding at a lipid-exposed site, without increasing their potency due to the presence of antagonism.
  • Researchers modified the chemical structure of PAMs by introducing various substitutions and extensions to improve their allosteric binding to both human and mouse AARs.
  • The mechanism behind this improvement involves a flexible chain that interacts with the lipid environment, indicating a novel way of stabilizing the PAM binding through electrostatic interactions with phospholipid head groups.
View Article and Find Full Text PDF

Genetic and functional modulation by agonist MRS5698 and allosteric enhancer LUF6000 at the native A adenosine receptor in HL-60 cells.

Purinergic Signal

October 2024

Molecular Recognition Section, Laboratory of Bioorganic Chemistry, NIDDK, National Institutes of Health, 9000, Rockville Pike, Bethesda, MD, 20892, USA.

The A adenosine receptor (AR) is an important inflammatory and immunological target. However, the underlying mechanisms are not fully understood. Here, we report the gene regulation in HL-60 cells treated acutely with highly selective AAR agonist MRS5698, positive allosteric modulator (PAM) LUF6000, or both.

View Article and Find Full Text PDF
Article Synopsis
  • Microglial activation is linked to brain changes in neurodegenerative diseases, and A adenosine receptors are explored as possible treatment targets.
  • RNA sequencing of activated microglia treated with selective A receptor antagonists and agonists showed no significant changes in classic microglial polarization genes, but many immune system-related genes were downregulated.
  • Researchers identified AC122413.1 and Olfr56 as potentially important genes affected by the treatments, suggesting their products could serve as biomarkers for microglial activation phenotypes.
View Article and Find Full Text PDF

First Potent Macrocyclic A Adenosine Receptor Agonists Reveal G-Protein and β-Arrestin2 Signaling Preferences.

ACS Pharmacol Transl Sci

September 2023

Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892, United States.

()-Methanocarba adenosine derivatives (A adenosine receptor (AR) agonists containing bicyclo[3.1.0]hexane replacing furanose) were chain-extended at and C2 positions with terminal alkenes for ring closure.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!